Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-13-001366
Filing Date
2013-05-08
Accepted
2013-05-08 16:44:55
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zk1313055.htm 10-Q 722389
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 10564
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 10875
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5770
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5563
  Complete submission text file 0001178913-13-001366.txt   4891538

Data Files

Seq Description Document Type Size
6 INSTANCE DOCUMENT psti-20130331.xml EX-101.INS 719209
7 TAXONOMY EXTENSION SCHEMA psti-20130331.xsd EX-101.SCH 45698
8 TAXONOMY EXTENSION CALCULATION LINKBASE psti-20130331_cal.xml EX-101.CAL 51200
9 TAXONOMY EXTENSION LABEL LINKBASE psti-20130331_lab.xml EX-101.LAB 595153
10 TAXONOMY EXTENSION PRESENTATION LINKBASE psti-20130331_pre.xml EX-101.PRE 251187
11 TAXONOMY EXTENSION DEFINITION LINKBASE psti-20130331_def.xml EX-101.DEF 157651
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31392 | Film No.: 13825111
SIC: 2836 Biological Products, (No Diagnostic Substances)